Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: A multicenter effectiveness and safety study

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 5, 2000, Pages 1191-1199

  Moutquin, Jean Marie ^a   Sherman, Dan ^g   Cohen, Howard ^c   Mohide, Patrick T ^d   Hochner Celnikier, Drorith ^h   Fejgin, Moshe ⁱ   Liston, Robert M ^e   Dansereau, Jerome ^f   Mazor, Moshe ^j   Shalev, Eliezer ^k   Boucher, Marc ^b   Glezerman, Marek ^j   Zimmer, Etan Z ^l   Rabinovici, Jaron ^m  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^e IWK HEALTH CENTRE   (Canada)

^f CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^g ASSAF HAROFEH MEDICAL CENTER   (Israel)

^h HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

ⁱ MEIR MEDICAL CENTER   (Israel)

^j BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^k HAEMEK MEDICAL CENTER   (Israel)

^l RAMBAM MEDICAL CENTER   (Israel)

^m SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

Atosiban; Oxytocin antagonists; Preterm labor; Ritodrine; Tocolysis; Adrenergic agents

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR; OXYTOCIN ANTAGONIST; RITODRINE;

ARTICLE; BIRTH WEIGHT; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN MORBIDITY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOCOLYSIS; TREATMENT OUTCOME;

EID: 0034048090     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.104950     Document Type: Article

References (25)

1. 1. Hall MH, Danielian P, Lamont RF. The importance of preterm birth. In: Elder MG, Lamont RF, Romero R, editors. Preterm labor. New York: Churchill Livingstone; 1997. p. 1-28.
2. 2. Cole RM, Lamont RF. Current perspectives on drug treatment for preterm labour. J Obstet Gynaecol 1998;18:309-14.
3. 3. King JF, Grant AM, Keirse MJ, Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 1988;95:211-22.
4. 4. Lamont RF, Dunlop PD, Crowley P, Levene MI, Elder MG. Comparative mortality and morbidity of infants transferred in utero or postnatally. J Perinat Med 1983;11:200-3.
5. 5. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration prior to preterm delivery: an overview from the evidence from controlled trials. Br J Obstet Gynaecol 1990;97:11-25.
6. 6. Lamont RF. The contemporary use of β-agonists. Br J Obstet Gynaecol 1993;100:890-2.
7. 7. Balducci J, Risek B, Gilula NB, Hand A, Egan JF, Vintzileos AM. Gap junction formation in human myometrium: a key to preterm labor? Am J Obstet Gynecol 1993;168:1609-15.
8. 8. Fuchs AR, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in pregnant human uterus. Am J Obstet Gynecol 1984;150:1396-8.
9. 9. Melin P. Development of an oxytocin antagonist atosiban. Res Clin Forum 1994;16:155-68.
10. 10. Zeeman GG, Khan-Dawood FS, Dawood MY. Oxytocin and its receptor in pregnancy and parturition: current concepts and clinical implications. Obstet Gynecol 1997;89:873-83.
11. 11. Bossmar T, Akerlund M, Fantoni G, Szamatowicz J, Melin P, Maggi M. Receptors for myometrial responses to oxytocin and vasopressin in preterm human pregnancy: effects of the oxytocin antagonist atosiban. Am J Obstet Gynecol 1994;171:1634-42.
12. 12. Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994;170:474-8.
13. 13. Goodwin TM, Valenzuela G, Silver H, Hayashi R, Creasy GW, Lane R. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996;13:143-6.
14. 14. Goodwin TM, Valenzuela GJ, Silver H, Creasy G. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstet Gynecol 1996;88:331-6.
15. 15. Anonymous. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. The Canadian Preterm Labor Investigators Group. N Engl J Med 1992;327:308-12.
16. 16. Stokes M, Davis C, Koch H. Categorical data analysis using the SAS system. Cary (NC): SAS Institute; 1995.
17. 17. Macones GA, Berlin M, Berlin JA. Efficacy of oral beta-agonist maintenance therapy in preterm labor: a meta-analysis. Obstet Gynecol 1995;85:313-7.
18. 18. Leveno KJ, Little BB, Cunningham FG. The national impact of ritodrine hydrochloride for inhibition of preterm labor. Obstet Gynecol 1990;76:12-5.
19. 19. Gupta RC, Foster S, Romano PM, Thomas HM. Acute pulmonary edema associated with the use of oral ritodrine for preterm labor. Chest 1989;95:479-81.
20. 20. Hudgens DR, Conradi SE. Sudden death associated with terbutaline sulfate administration. Am J Obstet Gynecol 1993; 169;120-1.
21. 21. Sibai BM, Romero R, Sanchez-Ramos L, Valenzuela G, Veille JC, Tabor B, et al. A double-blind, placebo-controlled trial of an oxytocin-receptor antagonist (Antocin) in the treatment of preterm labor [abstract]. Am J Obstet Gynecol 1997;176(1 Pt 2):S2.
22. 22. Sanchez-Ramos L, Valenzuela G, Romero R, Silver H, Koltun W, Millar L, et al. A double-blind, placebo-controlled trial of oxytocin receptor antagonist (Antocin) maintenance therapy in patients with preterm labor [abstract]. Am J Obstet Gynecol 1997;176(1 Pt 2):S30.
23. 23. Silver H, Valenzuela G, Sanchez-Ramos L, Romero R, Sibai B, Goodwin T, et al. Maternal side effects and safety of the oxytocin receptor antagonist Antocin [abstract]. Am J Obstet Gynecol 1997;176(1 Pt 2):S45.
24. 24. Robertson PA, Sniderman SH, Laros RK, Cowan R, Heilbron D, Goldenberg RL. Neonatal morbidity according to gestational age and birthweight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol 1992; 166:1629-41.
25. 25. Keirse MJ. New perspectives for the effective treatment of preterm labor. Am J Obstet Gynecol 1995;173:618-28.